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The intensity of fluorescence emission of each sample was measured by using FCM. Cell suspensions were vortexed briefly before analysis on a Becton and Dickinson FACSCalibur flow cytometer (BD, Franklin Lakes, NJ) with 488 nm argon ion laser. Samples were maintained in the dark during the analysis to avoid photobleaching. MFIs were obtained in the FL-1 channel in log mode. Ten thousand events were analyzed per sample. Data were collected using Cell Quest Pro software (BD, Franklin Lakes, NJ) and analyzed by Cyflogic v. 1.2.1 software (CyFlo, Ltd., Turku, Finland). MESF calibration was done using Quantum Alexa Fluor-488 MESF beads (Bangs Laboratories, Inc., Fishers, IN) according to the instructions of the manufacturer.
Confocal microscopy studies
P2Y 6 R-expressing astrocytoma cells were seeded into Nunc Lab-Tek 8-well chambered coverglass (Nalgene Nunc, Thermo Fischer Scientific, Rochester, NY) in a concentration confluent after 48 h. When 70% confluency was reached, the medium was refreshed with warm media, and cells were incubated in the presence or absence of 16 (2 µM) or 17 (100 nM-1 µM) for 60 min. After 60 min, cells were observed using Zeiss LSM 700 confocal laser scanning microscope and LSM Software ZEN 2009 (Carl Zeiss Microscopy GmbH, Germany). Results are shown in Figure 3 .
Fluorescence microscopy studies using known P2Y6R ligands
P2Y 6 R-expressing astrocytoma cells were grown on glass cover slips placed in a 6-well plate. When the cells reached 80% confluence the medium was replaced with fresh medium and competitive ligands were added to the cells and incubated for 30 min 37 ºC, followed by addition of 16 (final conc. 500 nM) and incubation for 60 min at 37 ºC. At the end of the incubation, the cells were washed with ice-cold PBS and mounted on a glass slide. The cells were visualized using a Keyence BZ-9000 fluorescent microscope equipped with filters for green fluorescence with excitation at 495 nm and emission at 519 nm. Results are shown in Figure 4 .
Data analysis
All data were analyzed by non-linear least squares analysis (GraphPad Prism Software, San Diego, CA).
The MFIs were corrected with the subtraction of autofluorescence values of 1321N1 astrocytoma cells in the absence of any ligand and converted into MESF values using QuickCal program v. 2.3 (Bangs Laboratories, Inc., Fishers, IN)
Results

Spectral characterization of 16
The absorption spectrum of 5 µM 16 aqueous solution displays a maximum at 494 nm, so the fluorescence emission spectra was performed using an excitation wavelength of 494 nm and detecting emission from 470 to 570 nm, the maximum emission was measured at 518 nm ( Figure  S2 ). 
Fluorescent ligand binding experiments with FCM
Saturation binding studies of the binding of 16 to the P2Y 6 R were performed by measuring the MFI with FCM. A saturation binding curve of 16 to 1321N1-P2Y 6 R was obtained using MESF values ( Figure 1B ). An apparent K D value of 380 ± 10 nM was determined. We were not able to obtain saturation binding curves at P2Y 1 Rs, the binding of the fluorescent compound was non-saturable, and could not be blocked by selective and potent antagonist MRS2500 ( Figure S3 ). 1321N1-P2Y 1 R and 1321N1-P2Y 6 R in the absence of fluorescence ligand were used to measure autofluorescence, nonspecific binding was measured in the presence of 100 µM UDP or 10µM MRS2500 on P2Y 6 and P2Y 1 , respectively. A FCM histogram of the total binding, nonspecific binding and the autofluorescence of 1321N1-P2Y 6 R using 400 nM 16 and 3h incubation is shown in Figure 1A .
Association kinetics of the fluorescent ligand 16 to the hP2Y 6 R was also determined using a FCM assay. Figure S5 shows the time-dependent binding of 400 nM 16 to 1321N1-P2Y 6 R cells. The t 1/2 was 37 min, and the association rate constant (K) was calculated to be 0.019 min -1 . Incubation with inhibitors followed by brief exposure to 16: 1321N1-P2Y 6 R cells were grown in 12-well plates overnight and on the day of the experiment, fresh media was added. Cells were pre-incubated with non-fluorescent P2Y 6 R ligands for 30 min, and then the cells were treated with fluorescent 16 for 2 min. At the end of the incubation, cells were washed twice with ice-cold PBS and the cells were detached from the plate using 0.2% EDTA. The cells were washed again with PBS and dissolved in 0.5 ml PBS and analyzed by FCM ( Figure S6 , FACSCalibur, BD Biosciences, San Jose, CA).
Internalization studies
It is well-known that acid stripping cells by washing with low pH solutions readily dissociates most ligands from their receptors. 3 It was also reported that hypertonic treatment (with 0.4 M sucrose) effectively blocks receptor endocytosis. 1, 2 We used these two methods to determine the surface bound and the internalized amount of fluorescent ligand during the time course of incubation.
The internalization process of the agonist-occupied P2Y 6 R using fluorescent 16 was characterized using FCM during a 3-hour long incubation (Figure 2A, B) . At each time point, the internalized amount of fluorescent ligand was determined by removal of the cell-surface bound ligand by washing in acidic aqueous medium (pH 3.5). The internalization occurred gradually, with a t 1/2 of 18 min ( Figure 2A ). After 60 min, the kinetic plot of receptor internalization reached its plateau, at which point 77% of the fluorescent compound was found in the intracellular compartment. Figure 2B shows the surface bound and internalized fractions of the fluorescent compound 16 after 60 min of incubation, in comparison with the nonspecific and the total binding. After reaching the plateau, only 17 % of the total binding was surface bound, 77 % was internalized and 23% of the total binding was nonspecifically bound.
A fluorescence micrograph also shows that after 60 min incubation, and fluorescence derived from exposure to 2 µM 16 mostly appears inside the 1321N1-P2Y 6 R cells rather than on S6 the cell surface ( Figure 2C ), which corresponds to the previous observations using FCM. In the absence of 16, there was no significant cell-fluorescence.
S7
Experimental procedures
Sequence alignment. The sequence of the hP2Y 6 R was added to our published alignment of the CXCR4, P2Y 1 , P2Y 2 and P2Y 4 Rs and was aligned to the others using the sequence alignment algorithm implemented in MOE, 1 with the BLOSUM62 matrix and penalties for gap starts and extensions set to 7 and 4, respectively. The resulting sequence alignment is shown in Figure S7 .
The template. The template for the homology modeling was prepared with MOE. 1 Our published CXCR4-based 2 model of the P2Y 4 R was then used as the template for the construction of a CXCR4-based P2Y 6 R model. 3 Prior to the construction of the model, the ligand docked into the P2Y 4 R was transformed into UDP by deleting the -phosphate and substituting the alkoxyimino group at position 4 of the pyrimidine ring with a carbonyl oxygen atom. Moreover, we changed the puckering of the ribose moiety to the southern (S) conformation, which we demonstrated to be a requirement for binding of UDP to the P2Y 6 R. This was done by subjecting the ribose to energy minimization, with the PFROSST force field, while restraining the dihedral angle between the C3', C2', C1' and O4' atoms to a value comprised between 30° and 40°. Before the energy minimization procedure, the partial charges of the ligands were calculated with the AM1-BCC semiempirical method. The energy minimization was terminated when the potential energy gradient reached the cutoff value of 0.05 kcal/(mol Å).
Construction of the homology model. The homology model was constructed with MOE. 1 Ten models were built and scored on the basis of electrostatic solvation energy (GB/VI). Intermediate and final models were subjected to energy minimizations with the PFROSST force field, with the refinement level set to "medium". We chose the "medium" refinement protocol, which is based on a brief cycle of energy minimizations intended to relief steric strain, to prevent from drifting away excessively from the template.
Optimization of the receptor model. The model was subsequently optimized with the "protein preparation wizard" workflow, as implemented in the Schrödinger package 4 to add hydrogen atoms and and calculate the protonation states of ionizable groups at pH 7. The workflow also optimized the orientation of hydroxyl groups, as well as Asn, Gln and His residues. Finally, the hydrogen atoms were minimized with the Impact molecular mechanics engine, allowing a maximum root mean square deviation (RMSD) of 0.30 Å from the original structure, whereas heavy atoms were held rigid.
Modeling of the receptor-ligand interactions.
The study of the receptor-ligand interactions was conducted with the Schrodinger package and its MacroModel molecular mechanics engine. 4 Compound 16 was sketched from UDP through the Maestro interface of the Schrödinger package, 4, 5 by substituting the carbonyl group at position 4 of the pyrimidine ring with the large alkoxyimino group characteristic of the fluorescent ligand. The compound was then subjected to two rounds of energy minimization, conducted with the OPLS2005 force field and protracted until the potential energy gradient reached the cutoff value of 0.05 kJ/(mol Å), followed by 1000 steps of Monte Carlo conformational search. In the first round, flexibility was granted only to the large alkoxyimino substituent, while a shell of residues located within 5 Å from the flexible atoms where considered for the calculation of the potential energy but were held rigid. In the second minimization round and the subsequent Monte Carlo search, flexibility was granted only S8 to the entire ligand as well as all the residues located within 5 Å from. An additional shell of residues located within 5 Å from the flexible atoms where considered for the calculation of the potential energy but were held rigid. The lowest energy structure resulting from the MCMM calculation and all the structures within 20 kJ/mol from it were saved in the output of the conformational search. Figure S4. Fluorescent images using compound 17. 1321N1-P2Y 6 R cells were incubated with the fluorescent compound in different concentrations (100 nM-1µM) for 60 min at 37 °C, and fluorescent images were recorded using Zeiss LSM 700 confocal microscope. Although intense fluorescent labeling was observed with a 100 nM concentration of 17, it could not be blocked using P2Y 6 R agonist UDP (100 µM). 
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O-(3-Iodobenzyl)-hydroxylamine hydrochloride (28)
O-(3-Iodobenzyl)-hydroxyphthalimide according to the previous experiment was dissolved in 4
mL of ethanol and treated with hydrazine hydrate (0.146 mL,1.86 mmol, 1.1 equiv.). The reaction mixture was refluxed at 78 °C for 1.5 h. After completion, reaction mixture was cooled and 3% Na 2 CO 3 (5 mL) was added and the mixture extracted with ether (20 mL x 3). Anhydrous sodium sulfate was added to the combined organic portion, filtered and dried. Then crude mixture was redissolved in 2 mL of CH 2 Cl 2 , and 1. was added, and the reaction mixture was stirred for 30 min at room temperature. The mixture was lyophilized overnight and the residue was purified by Sephadex-DEAE resin ion-exchange column chromatography, followed by semipreparative HPLC as described above to obtain compound 10 (3 mg, 3.8 x 10 -3 mmol, 8% yield). 
-(O-(3-Iodobenzyloxy))-cytidine-5-diphosphate diethyl ammonium salt (11)
Compound 11 was synthesized according to the previous procedure (3 mg, 3.5 x 10 -3 mmol, 8%
yield. in DMF (0.03 mL) were added. After stirring the reaction mixture at rt for 16 h, the solvent was removed and water (1 mL) was added. The resulting solid was removed by filtration, and the filtrate was purified by semipreparative HPLC as described above to obtain 23 (1.89 mg, 40%)
as a white amorphous solid. To a mixture of N-(2-azidoethyl)acetamide 45 (1.26 mg, 9.90 μmol, 1.5 eq) and dialkyne 22 (4.8 mg, 6.60 μmol, 1.5 eq) in a 0.35 mL of (2:3:5) mixture of water, t BuOH and ethanol, was added freshly prepared 1 M aqueous sodium ascorbate solution (6.68 μL, 6.68 μmol, 1 eq) followed by 7.5% aqueous copper sulfate pentahydrate solution (11.15 μL, 3.33 μmol. 0.5 eq). The reaction mixture was stirred overnight at room temperature, solvent was evaporated, and the residue was purified by semipreparative HPLC as described above to obtain 24 (0.38 mg, 2.6 %) as a white Reference:
